Wei-Chiao Chang

Title: Wei-Chiao Chang: Innovator in Genetic Biomarkers

Introduction

Wei-Chiao Chang is an inventor based in Kaohsiung City, Taiwan. He is known for his innovative approaches to determining risks associated with kidney stones and atopic dermatitis through genetic biomarkers. Although he currently holds no granted patents, his contributions to the field of genetic research are noteworthy.

Latest Patent Applications

Wei-Chiao Chang has filed several significant patent applications. One of his latest applications is titled "METHOD FOR DETERMINING RISK FOR KIDNEY STONES DEVELOPING OR RECURRING AND METHOD FOR USING SINGLE-NUCLEOTIDE POLYMORPHISM RS12313273 AS BIOMARKER FOR DETERMINING DEVELOPMENT OR RECURRENCE OF KIDNEY STONE." This invention provides a method for assessing the risk of kidney stones in a subject by detecting the presence of the single-nucleotide polymorphism rs12313273 in a biosample. If the presence of a C allele is detected, it indicates an increased risk for kidney stones.

Another notable application is "METHOD FOR DETERMINING A RISK, FOR A SUBJECT, OF SUFFERING FROM ATOPIC DERMATITIS OR SEVERITY OF ATOPIC DERMATITIS FOR A SUBJECT SUFFERING FROM ATOPIC DERMATITIS AND METHOD FOR USING A SINGLE-NUCLEOTIDE POLYMORPHISM RS12313273 AS A BIOMARKER FOR DETERMINING THE DEVELOPMENT OR SEVERITY OF ATOPIC DERMATITIS." This invention outlines a method for determining the risk of atopic dermatitis by analyzing the same single-nucleotide polymorphism, where the presence of a C allele or genotype CC indicates an increased risk for the condition.

Conclusion

Wei-Chiao Chang's work in the field of genetic biomarkers highlights the potential for innovative methods to assess health risks. His latest patent applications reflect a commitment to advancing medical research and improving patient outcomes.